---
title: "Eli Lilly and Company (LLY.US) 1Q 2022 Earnings Call"
description: "Eli Lilly and Company specializes in the discovery, development, manufacturing, and sales of pharmaceutical products. Its products include therapies for diabete"
locale: "en"
url: "https://longbridge.com/en/lives/11093"
parent: "https://longbridge.com/en/lives.md"
category: "Earnings Call"
---

# Eli Lilly and Company (LLY.US) 1Q 2022 Earnings Call

**Status**: Unknown
**Category**: Earnings Call

## Description

Eli Lilly and Company specializes in the discovery, development, manufacturing, and sales of pharmaceutical products. Its products include therapies for diabetes, oncology, immunology, neuroscience, and other areas. Diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta, and Trulicity. Oncology products include Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. Immunology products include Olumiant and Taltz. Neuroscience products consist of Cymbalta, Emgality, Reyvow, and Zyprexa. Other therapies include Bamlanivimab, Cialis, and Forteo. The company was founded by Eli Lilly and Company in May 1876 and is headquartered in Indianapolis.

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.